Row 28399

Row ID: 28399 | Dataset Entry | Axioma AXP Content Repository

Content Data

This page contains data entry 28399 from the Axioma AXP content repository. The structured data below represents the complete record for this entry.

I think the immediate answer is NO! AI or ML based pipelines have largely helped automating repetitive stuff, like counting cells on slides from biopsy, or recommending the correct treatment. The major things are probably the Davinci operating system, and AlphaFold3. But there is no grand advancements derived from AI that can produce better drugs or diagnose hard cases. The reason for that being is partly the gap between AI experts and the medicine industry, and partly the lack of data and quality data at that. I think also a huge part for the absence of major advancement can be attributed to the lack of commercial upside in system biology and quantitative biology research. Even if you discover something significant, it will takes many years until you see any return, and therefore it is less inviting than other AI ventures that are more profitable by many miles.

FieldValue
text I think the immediate answer is NO! AI or ML based pipelines have largely helped automating repetitive stuff, like counting cells on slides from biopsy, or recommending the correct treatment. The major things are probably the Davinci operating system, and AlphaFold3. But there is no grand advancements derived from AI that can produce better drugs or diagnose hard cases. The reason for that being is partly the gap between AI experts and the medicine industry, and partly the lack of data and quali…
label r/machinelearning
dataType comment
communityName r/MachineLearning
datetime 2024-05-21
username_encoded Z0FBQUFBQm5Lak1FQVJXN0xPTi1TUXdyVXQwcU10Nl9qZVVMaVBCS1F1eHBPOFkxWGlORmtUdEQxVm51aklIOERBT0xfdEJFaC14eUhjcWR6ejUzeWd2Q2JBRVFEd0VXOWE5bmZTMHBzTTZtOTF4eXEyQ0oxM2c9
url_encoded Z0FBQUFBQm5Lak9UUGduaEF6NHJBWC0wenZEYkowd3hnWG4ycUNvSVFtMkdtNmQtNE91WHZEVVJWX1A4Z2JoUzdIUnRFYzNvMkFQZ1BLTGVPTzBKdDdoa1V6TE1kZXA2QXE5aENrRFdtbXg4WmpaV181WTZpMlJhekpLTEI4YWJrQURUdzhtekFuR1FEODVsUDdxaG50d1lRYkpkQ0o3cno5THYzel94UzloN2J4LVJ0LUl4b3FSU0gxZUVLVWs5ODFDbTRyYzNkVmRqMUpwd0dUcF9GeDg4RFpfR0hrWmxiWUZUdk9BUWlIaFZJVV91RDY1S0hRQT0=

Raw Record

{
  "text": "I think the immediate answer is NO! AI or ML based pipelines have largely helped automating repetitive stuff, like counting cells on slides from biopsy, or recommending the correct treatment. The major things are probably the Davinci operating system, and AlphaFold3. But there is no grand advancements derived from AI that can produce better drugs or diagnose hard cases. The reason for that being is partly the gap between AI experts and the medicine industry, and partly the lack of data and quality data at that. I think also a huge part for the absence of major advancement can be attributed to the lack of commercial upside in system biology and quantitative biology research. Even if you discover something significant, it will takes many years until you see any return, and therefore it is less inviting than other AI ventures that are more profitable by many miles.",
  "label": "r/machinelearning",
  "dataType": "comment",
  "communityName": "r/MachineLearning",
  "datetime": "2024-05-21",
  "username_encoded": "Z0FBQUFBQm5Lak1FQVJXN0xPTi1TUXdyVXQwcU10Nl9qZVVMaVBCS1F1eHBPOFkxWGlORmtUdEQxVm51aklIOERBT0xfdEJFaC14eUhjcWR6ejUzeWd2Q2JBRVFEd0VXOWE5bmZTMHBzTTZtOTF4eXEyQ0oxM2c9",
  "url_encoded": "Z0FBQUFBQm5Lak9UUGduaEF6NHJBWC0wenZEYkowd3hnWG4ycUNvSVFtMkdtNmQtNE91WHZEVVJWX1A4Z2JoUzdIUnRFYzNvMkFQZ1BLTGVPTzBKdDdoa1V6TE1kZXA2QXE5aENrRFdtbXg4WmpaV181WTZpMlJhekpLTEI4YWJrQURUdzhtekFuR1FEODVsUDdxaG50d1lRYkpkQ0o3cno5THYzel94UzloN2J4LVJ0LUl4b3FSU0gxZUVLVWs5ODFDbTRyYzNkVmRqMUpwd0dUcF9GeDg4RFpfR0hrWmxiWUZUdk9BUWlIaFZJVV91RDY1S0hRQT0="
}

Entry Information